Cardiovascular surgery in COVID-19: Change and countermeasure
- VernacularTitle:新冠疫情下的心脏外科：改变与应对之策
- Author:
Jiade ZHU
1
,
2
,
3
;
Huiming GUO
1
,
2
,
3
Author Information
1. 1. Department of Cardiovascular Surgery, Guangdong Provincial People&rsquo
2. s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, P. R. China
3. 2. Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangzhou, 510080, P. R. China
- Publication Type:Journal Article
- Keywords:
COVID-19 pandemic;
cardiac surgery;
diagnosis and therapy strategy;
management strategy
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2023;30(02):162-166
- CountryChina
- Language:Chinese
-
Abstract:
The coronavirus disease 2019 (COVID-19) epidemic has a tremendous impact on the countries around the world since the outbreak in December 2019. From December 2022, with the loosening of domestic epidemic control policies, the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rose significantly and reached to its epidemic peak in the majority of the cities in China, which further overwhelmed our medical care system. The cardiac surgery departments in China lack the experience in conducting work under the COVID-19 pandemic. In this paper, we summarize the main topics that might be faced during the pandemic by reviewing the previous related literatures, which included: the cardiac surgery volume trends, the impact of SARS-CoV-2 infection on the prognosis of cardiac surgery, the timing of cardiac surgery and the surgical strategy should be modified, and possible recommendations for the manager or governors during the pandemic, so as to outline a path forward for cardiac surgery for the near future.
